Clinical Trials Browser

Cardiotoxicity × Razoxane × Sarcoma × Clear all

NCT00003937 2014-08-05

Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma

Phase 3 Completed

Sarcoma, Cardiotoxicity